Biotech News - Millennium Pharmaceuticals, Inc. (Public, NASDAQ:MLNM)

Millennium Pharmaceuticals, Inc. (Public, NASDAQ:MLNM)

CIBC World Markets 17th Annual Healthcare Conference to Webcast
Millennium Presentation

Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company
based in Cambridge, Mass., markets VELCADE(R) (bortezomib) for
Injection, a novel cancer product, and has a robust clinical
development pipeline of product candidates. The Company's research,
development and commercialization activities are focused in two
therapeutic areas: oncology and inflammation. By applying its
knowledge of the human genome, understanding of disease mechanisms and
industrialized drug discovery platform, Millennium is developing an
exciting pipeline of innovative product candidates

http://tech.groups.yahoo.com/group/biotech-news/
http://www.arizonabiotech.com/
http://www.azhttp.com/

http://www.arizonabiotech.com/
http://groups.yahoo.com/group/biotech-news/
http://www.arizonaentrepreneurs.com/
http://www.azhttp.com/

Yahoo! Groups Links

<*> To visit your group on the web, go to:
http://groups.yahoo.com/group/biotech-news/

<*> Your email settings:
Individual Email | Traditional

<*> To change settings online go to:
http://groups.yahoo.com/group/biotech-news/join
(Yahoo! ID required)

<*> To change settings via email:
mailto:biotech-news-digest@yahoogroups.com
mailto:biotech-news-fullfeatured@yahoogroups.com

<*> To unsubscribe from this group, send an email to:
biotech-news-unsubscribe@yahoogroups.com

<*> Your use of Yahoo! Groups is subject to:
http://docs.yahoo.com/info/terms/